Author:
Baumgarten H. G.,Zimmermann B.
Publisher
Springer Berlin Heidelberg
Reference241 articles.
1. Adams RN, Murrill E, McCreery R, Blank L, Karolczak M (1972) 6- Hydroxydopamine, a new oxidation mechanism. Eur J Pharmacol 17:287–292
2. Allis B, Cohen G (1977) The neurotoxicity of 5,7-dihydroxytryptamine in the mouse atrium: protection by l-phenyl-3-(2-thiazolyl)-2-thiourea and by ethanol. Eur J Pharmacol 43:269–272
3. Ames MM, Nelson SD, Lovenberg W, Sasame HA (1977) Metabolic activation of para-chloroamphetamine to a chemically reactive metabolite. Comm Psychopharmacol 1:455–460
4. Appel NM, Contrera JF, De Souza EB (1989) Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. J Pharmacol Exp Ther 249(3): 928–943
5. Amarego WLF, Waring P (1983) Inhibition of human brain dihydropteridine reductase (EC 1.6.99.10) by the oxidation products of catecholamines, the aminochromes. Biochem Biophys Res Commun 113:895–899